![Jason A. Campagna](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jason A. Campagna
Director Técnico/Científico/I+D en Q32 Bio, Inc. .
Fortuna: - $ al 31/05/2024
Cargos activos de Jason A. Campagna
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Q32 Bio, Inc.
![]() Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Director Técnico/Científico/I+D | - | - |
Historial de carrera de Jason A. Campagna
Antiguos cargos conocidos de Jason A. Campagna.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
PLANTABLE HEALTH INC. | Director/Miembro de la Junta | 26/11/2021 | 31/03/2023 |
Independent Dir/Board Member | 26/11/2021 | 31/03/2023 | |
INTERCEPT PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/12/2019 | 05/03/2021 |
THE MEDICINES COMPANY | Corporate Officer/Principal | - | 01/08/2016 |
ProFibrix BV
![]() ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Director Ejecutivo | - | - |
Annovation BioPharma, Inc.
![]() Annovation BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Annovation BioPharma, Inc. develops pharmaceutical products in the field of anesthesia, sedation and sleep. It is developing a rapid-acting anesthesia called Rapidate. The firm's novel agents are designed to allow more precise control of anesthesia and enable safer treatment of patients undergoing surgical procedures. The company was founded in 2009 by Nicholas Barker and is headquartered in Parsippany, NJ. | Director/Miembro de la Junta | - | - |
Formación de Jason A. Campagna.
University of Miami | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 6 |
Países Bajos | 2 |
Canadá | 2 |
Operativa
Chief Tech/Sci/R&D Officer | 3 |
Director/Board Member | 2 |
Corporate Officer/Principal | 1 |
Sectorial
Health Technology | 6 |
Consumer Services | 2 |
Retail Trade | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
PLANTABLE HEALTH INC. | Retail Trade |
Empresas privadas | 4 |
---|---|
Annovation BioPharma, Inc.
![]() Annovation BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Annovation BioPharma, Inc. develops pharmaceutical products in the field of anesthesia, sedation and sleep. It is developing a rapid-acting anesthesia called Rapidate. The firm's novel agents are designed to allow more precise control of anesthesia and enable safer treatment of patients undergoing surgical procedures. The company was founded in 2009 by Nicholas Barker and is headquartered in Parsippany, NJ. | Health Technology |
The Medicines Co.
![]() The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
ProFibrix BV
![]() ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Health Technology |
Q32 Bio, Inc.
![]() Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Jason A. Campagna
- Experiencia